| scholarly article | Q13442814 |
| P50 | author | Sonia Levi | Q37373890 |
| Michael D. Garrick | Q47796123 | ||
| P2093 | author name string | Jiang Qian | |
| Paolo Santambrogio | |||
| Arnulf H Koeppen | |||
| David J Haile | |||
| Mitchell D Knutson | |||
| Jacques B Lamarche | |||
| Susan C Michael | |||
| P2860 | cites work | Tin-protoporphyrin prevents experimental superficial siderosis in rabbits | Q44085923 |
| P433 | issue | 2 | |
| P921 | main subject | Friedreich ataxia | Q913856 |
| P304 | page(s) | 163-173 | |
| P577 | publication date | 2007-04-11 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins | |
| P478 | volume | 114 |
| Q41827616 | 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'. |
| Q34172946 | (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. |
| Q34940777 | A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds. |
| Q38121944 | Animal and cellular models of Friedreich ataxia. |
| Q37570362 | Ataxias with autosomal, X-chromosomal or maternal inheritance. |
| Q56986615 | Brain diffusion-weighted imaging in Friedreich's ataxia |
| Q37605018 | Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities |
| Q58586199 | Calcium Deregulation: Novel Insights to Understand Friedreich's Ataxia Pathophysiology |
| Q34150158 | Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia |
| Q30426640 | Cerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content. |
| Q37208491 | Cognition in Friedreich's ataxia: a behavioral and multimodal imaging study |
| Q48961926 | Cognitive deficits in Friedreich ataxia correlate with micro-structural changes in dentatorubral tract |
| Q48863338 | Combined Cerebellar Proton MR Spectroscopy and DWI Study of Patients with Friedreich's Ataxia |
| Q39241624 | Dentate Update: Imaging Features of Entities That Affect the Dentate Nucleus. |
| Q57086524 | Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia |
| Q55073764 | Drosophila melanogaster Models of Friedreich's Ataxia. |
| Q30602174 | Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia |
| Q38219400 | Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. |
| Q38219414 | Epigenetic-based therapies for Friedreich ataxia |
| Q36663928 | Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy |
| Q64093623 | Erythropoietin and Friedreich Ataxia: Time for a Reappraisal? |
| Q92251738 | Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia |
| Q48087593 | Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy |
| Q37686297 | Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia |
| Q42678097 | Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model |
| Q34984786 | Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus |
| Q34964308 | Friedreich ataxia: failure of GABA-ergic and glycinergic synaptic transmission in the dentate nucleus |
| Q34076650 | Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities |
| Q37278583 | Friedreich ataxia: neuropathology revised |
| Q36398625 | Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus |
| Q34708637 | Friedreich's ataxia: pathology, pathogenesis, and molecular genetics |
| Q28540063 | Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models |
| Q64044527 | Impact of Models in the Study and Treatment of Friedreich's Ataxia |
| Q33860305 | Iron homeostasis in peripheral nervous system, still a black box? |
| Q58716754 | Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon? |
| Q83179335 | Iron, copper, and zinc distribution of the cerebellum |
| Q24323371 | Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia |
| Q34531992 | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration. |
| Q37184523 | MRI findings in AOA2: Cerebellar atrophy and abnormal iron detection in dentate nucleus. |
| Q33901773 | Metal and complementary molecular bioimaging in Alzheimer's disease. |
| Q24619770 | Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia |
| Q43178831 | Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients |
| Q27015737 | Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease |
| Q37686294 | Mitochondrial metals as a potential therapeutic target in neurodegeneration |
| Q37480278 | Molecular and clinical investigation of Iranian patients with Friedreich ataxia. |
| Q31115799 | Overview of quantitative susceptibility mapping. |
| Q28486160 | Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia |
| Q37423316 | Pharmacotherapy for Friedreich ataxia |
| Q28743986 | Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model |
| Q42766637 | Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia |
| Q48108215 | Reply: To PMID 23328073. |
| Q35131313 | Rescue of the Friedreich ataxia knockout mutation in transgenic mice containing an FXN-EGFP genomic reporter |
| Q31014690 | Structural and Functional Magnetic Resonance Imaging of the Cerebellum: Considerations for Assessing Cerebellar Ataxias |
| Q41146062 | Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia |
| Q33643043 | Structural and functional magnetic resonance imaging of the human cerebellar nuclei |
| Q48691950 | Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: a case report |
| Q38570991 | Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration. |
| Q64040115 | The Role of Iron in Friedreich's Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models |
| Q40972199 | The in vivo reduction of afferent facilitation induced by low frequency electrical stimulation of the motor cortex is antagonized by cathodal direct current stimulation of the cerebellum |
| Q36973103 | The neuropathology of late-onset Friedreich's ataxia |
| Q26861733 | Therapeutic developments in Friedreich ataxia |
| Q26860523 | Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models |
Search more.